Neurokinin-1 Receptor Antagonists Protect Mice from CD95- and Tumor Necrosis Factor-α-Mediated Apoptotic Liver Damage

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 3, 2004, Pages 1174-1180

  Bang, Renate ^a   Biburger, Markus ^a   Neuhuber, Winfried L ^a   Tiegs, Gisa ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; CAPSAICIN; CASPASE 3; FAS ANTIGEN; GALACTOSAMINE; MONOCLONAL ANTIBODY; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; LIVER CELL; LIVER HOMOGENATE; LIVER INJURY; LIVER PROTECTION; LIVER SLICE; MOUSE; MUSCLE SPINDLE AFFERENT NERVE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; LIVER DISEASES; MICE; MICE, INBRED BALB C; NEURONS, AFFERENT; PROTECTIVE AGENTS; RECEPTORS, NEUROKININ-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1342287208     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.059329     Document Type: Article

References (44)

1. Bang R, Sass G, Kiemer AK, Vollmar AM, Neuhuber WL, and Tiegs G (2003) Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury. J Pharmacol Exp Ther 305:31-39.
2. Bergmeyer HU (1984) Methods of Enzymatic Analysis, 3rd ed, vol 82, pp 416-456, Verlag Chemie, Weinheim, Germany.
3. Bockmann S, Seep J, and Jonas L (2001) Delay of neutrophil apoptosis by the neuropeptide substance P: involvement of caspase cascade. Peptides 22:661-670.
4. Bowden JJ, Garland AM, Baluk P, Lefevre P, Grady EF, Vigna SR, Bunnett NW, and McDonald DM (1994) Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA 91:8964-8968.
5. Bracci-Laudiero L, Aloe L, Stenfors C, Theodorsson E, and Lundeberg T (1998) Development of systemic lupus erythematosus in mice is associated with alterations of neuropeptide concentrations in inflamed kidneys and immunoregulatory organs. Neurosci Lett 248:97-100.
6. Casini A, Lippe IT, Evangelista S, Geppetti P, Santicioli P, Urso C, Paglierani M, Maggi CA, and Surrenti C (1990) Effect of sensory denervation with capsaicin on liver fibrosis induced by common bile duct ligation in rat. J Hepatol 11:302-312.
7. Costello RW, Fryer AD, Belmonte KE, and Jacoby DB (1998) Effects of tachykinin NK1 receptor antagonists on vagal hyperreactivity and neuronal M2 muscarinic receptor function in antigen challenged guinea-pigs. Br J Pharmacol 124:267-276.
8. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, and Bunnett NW (2000) The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 97:11086-11091.
9. del Rio G, Castro-Obregon S, Rao R, Ellerby HM, and Bredesen DE (2001) APAP, a sequence-pattern recognition approach identifies substance P as a potential apoptotic peptide. FEBS Lett 494:213-219.
10. Dimri R, Sharabi Y, and Shoham J (2000) Specific inhibition of glueocorticoid-induced thymocyte apoptosis by substance P. J Immunol 164:2479-2486.
11. Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, Korc M, Palma C, Zimmermann A, et al. (2003) Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Investig 83:731-742.
12. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK 3rd, Schuchman EH, Fuks Z, and Kolesnick R (1997) Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186:1831-1841.
13. Harrison S and Geppetti P (2001) Substance P. Int J Biochem Cell Biol 33:555-576.
14. Heasley LE (2001) Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 20:1563-1569.
15. Holzer P (1988) Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24:739-768.
16. Jaeschke H (2003) Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol 284:G15-G26.
17. Janin A, Deschaumes C, Daneshpouy M, Estaquier J, Micic-Polianski J, Rajagopalan-Levasseur P, Akarid K, Mounier N, Gluckman E, Socie G, et al. (2002) CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. Blood 99:2940-2947.
18. Kincy-Cain T and Bost KL (1996) Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II. J Immunol 157:255-264.
19. Künstle G, Hentze H, Germann P-G, Tiegs G, Meergans T, and Wendel A (1999) Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation. Hepatology 30:1241-1251.
20. Leist M, Gantner F, Kunstle G, Bohlinger I, Tiegs G, Bluethmann H, and Wendel A (1996) The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med 2:109-124.
21. Lin YS, Ho CY, Tang GJ, and Kou YR (2001) Alleviation of wood smoke-induced lung injury by tachykinin receptor antagonist and hydroxyl radical scavenger in guinea pigs. Eur J Pharmacol 425:141-148.
22. Liu H, Cao Y, Basbaum AI, Mazarati AM, Sankar R and Wasterlain CG (1999) Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. Proc Natl Acad Sci USA 96:12096-12101.
23. Lotz M, Vaughan JH, and Carson DA (1988) Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science (Wash DC) 241:1218-1221.
24. Markus AM, Kockerling F, and Neuhuber WL (1998) Close anatomical relationship between nerve fibers and MHC class II-expressing dendritic cells in the rat liver and extrahepatic bile duct. Histochem Cell Biol 109:409-415.
25. Marriott I and Bost KL (2000) IL-4 and IFN-γ up-regulate substance P receptor expression in murine peritoneal macrophages. J Immunol 165:182-91.
26. Marriott I, Mason MJ, Elhofy A, and Bost KL (2000) Substance P activates NF-κB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J Neuroimmunol 102:163-171.
27. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, and Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature (Lond) 364:806-809.
28. Perretti M, Ahluwalia A, Flower RJ, and Manzini S (1993) Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology 80:73-77.
29. Quartara L and Maggi CA (1998) The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides 32:1-49.
30. Rameshwar P, Ganea D, and Gascon P (1994) Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. J Immunol 152:4044-4054.
31. Rupniak NM, Carlson E, Boyce S, Webb JK, and Hill RG (1996) Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils. Pain 67:189-195.
32. Rupniak NM and Kramer MS (1999) Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 20:485-490.
33. Santoni G, Amantini C, Lucciarini R, Pompei P, Perfumi M, Nabissi M, Morrone S, and Piccoli M (2002) Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation. Neuroimmunomodulation 10:232-246.
34. Sass G, Soares MCP, Yamashita K, Seyfried S, Zimmermann WH, Eschenhagen T, Kaczmarek E, Ritter T, Volk HD, and Tiegs G (2003) Heme oxygenase-1 and its reaction product carbon monoxide prevent inflammation-related apoptotic liver damage in mice. Hepatology 38:909-918.
35. Schümann J and Tiegs G (1999) Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. Toxicology 138:103-126.
36. Seglen PO (1973) Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res 82:391-398.
37. Seino K, Kayagaki N, Takeda K, Fukao K, Okumura K, and Yagita H (1997) Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113:1315-1322.
38. 1) receptor. Science (Wash DC) 251:435-437.
39. Stoyanova II and Gulubova MV (1998) Peptidergic nerve fibres in the human liver. Acta Histochem 100:245-256.
40. Tiegs G, Bang R, and Neuhuber WL (1999) Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by β-adrenergic stimulation. J Neuroimmunol 96:131-143.
41. Tiegs G, Wolter M, and Wendel A (1989) Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 38:627-631.
42. Veronesi B, Sailstad DM, Doerfler DL, and Selgrade M (1995) Neuropeptide modulation of chemically induced skin irritation. Toxicol Appl Pharmacol 135:258-267.
43. Wanner GA, Mica L, Wanner-Schmid E, Kolb SA, Hentze H, Trentz O, and Ertel W (1999) Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity. FASEB J 13:1239-48.
44. Zachrisson O, Lindefors N, and Brene S (1998) A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Brain Res Mol Brain Res 60:291-295.